Author:
Hirsch F.R.,Varella-Garcia M.,Cappuzzo F.,McCoy J.,Bemis L.,Xavier A.C.,Dziadziuszko R.,Gumerlock P.,Chansky K.,West H.,Gazdar A.F.,Crino L.,Gandara D.R.,Franklin W.A.,Bunn P.A.
Reference45 articles.
1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005
2. Cancer statistics, 2006;Jemal;CA Cancer J Clin,2006
3. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer;Fukuoka;J Clin Oncol,2003
4. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial;Kris;JAMA,2003
5. A phase II trial of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor OSI-774, following platinum-based chemotherapy, in patients (pts) with advanced, EGFR-expressing, non-small cell lung cancer (NSCLC);Perez-Soler;Proc Am Soc Clin Oncol,2001
Cited by
245 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献